Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1999
11/18/1999WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058162A2 Pharmaceuticals for the imaging of angiogenic disorders
11/18/1999WO1999058139A2 Methods for detecting and inhibiting angiogenesis
11/18/1999WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
11/18/1999WO1999058095A2 Pharmaceutical and/or cosmetic compositions containing sea water
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2332616A1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and their uses
11/18/1999CA2331879A1 Oxyiminoalkanoic acid derivatives
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328414A1 Methods for detecting and inhibiting angiogenesis
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2327351A1 Cell signaling proteins
11/18/1999CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders
11/17/1999EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999EP0957091A1 Inhibitors of tumor necrosis factor alpha
11/17/1999EP0956294A1 Thrombin inhibitors
11/17/1999EP0956281A1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/17/1999EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
11/17/1999EP0956031A1 Inhibition of 26s and 20s proteasome by indanones
11/17/1999CN1235608A Alkylated reapamycin derivatives
11/17/1999CN1235603A N-substituted azaheterocyclic compounds
11/17/1999CN1235550A Synergistic gold-containing compositions
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1046515C Diazabicyclic neurokinin antagonists
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/17/1999CN1046506C Preparation of n-tert-butylamides derivatives and their salts
11/17/1999CN1046505C Preparation of 1-benzyl-3-hydroxymethyl-indazole and ether of aliphatic-2-hydroxy acid
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999US5985862 Treating undesired smooth muscle contractions and inflammatory diseases
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,
11/16/1999CA2169481C Method of inhibiting nitric oxide formation
11/16/1999CA2013599C Aryl-substituted rhodanine derivatives
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057148A1 Melanocortin 1 receptor selective compounds
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999056752A1 sPLA2 INHIBITOR ESTER
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology
11/11/1999WO1999056725A1 Pharmaceutical compositions capable of being gelled
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999WO1999045916A3 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
11/11/1999WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999WO1999040073A3 Tryptase inhibitors
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2331036A1 Spla2 inhibitor ester
11/11/1999CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2327550A1 Melanocortin 1 receptor selective compounds
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955372A2 Method for screening substance inhibiting activation of NF-kappa B
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954576A2 Cd16-ii variants
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/10/1999EP0954321A1 Synergistic gold-containing compositions
11/10/1999EP0954310A1 Synergistic composition comprising rapamycin and calcitriol
11/10/1999EP0954303A2 Methods of treating mental diseases, inflammation and pain
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
1 ... 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 ... 1272